INTRODUCTION
other than the CP open reading frame (ORF) (Swaney et al., 1995) and against many types of virus, including Virus resistance in plants containing viral CP transpotexviruses Pang et al., 1996 ; Prins genes may be mediated by the protein or the RNA prodet al., 1996; Sijen et al., 1996) . We refer to this RNAuct of the transgene . Protein-medimediated process as homology-dependent resistance. ated resistance relies on the ability of transgenic CP to From earlier studies it is known that a transgene based interfere with functions of the viral CP that are essential on the CP ORF of PVX confers resistance to PVX (Hemenfor the infection cycle. If the CP molecule has multiple way et al., 1988) . This resistance is effective against RNA functions, the resistance may operate at several levels.
or virion inocula, indicating that PVX is suppressed at a For example, the tobacco mosaic virus (TMV) CP prolater stage in the infection cycle than virion disassembly. duced in transgenic tobacco caused resistance against However, it was not known whether this resistance was TMV by suppression of virion disassembly and viral vasmediated by protein or RNA. cular transport (Register and Beachy, 1988; Osbourn et In this report we describe an analysis that was deal., 1989; Wisniewski et al., 1990; Reimann-Philipp and signed to characterize the mechanism of PVX resistance Beachy, 1993) . Similarly CP-mediated resistance against in tobacco plants carrying PVX CP transgenes. Our findalfalfa mosaic virus (AlMV) operated at the level of virion ings suggest that the resistance was due primarily to disassembly and, in some lines, at the level of viral RNA inhibition of PVX RNA replication in the inoculated cell. replication (Taschner et al., 1994) .
Surprisingly, CP defects in mutant PVX could be comple-RNA-mediated virus resistance, as in transgenic plants mented in part by inoculation to these PVX-resistant containing the CP coding sequence of tobacco etch virus plants. We propose that these activities of the transgenic (TEV) or potato virus Y (PVY), involves degradation of viral CP are related to the roles of the CP in the normal PVX RNA species with a nucleotide sequence that is similar infection cycle. to that of the transgene ( Van der Vlugt et al., 1992; Lindbo et al., 1993; Smith et al., 1994; Goodwin et al., 1996) .
MATERIALS AND METHODS Although the first described examples of this RNA-mediated resistance involved CP transgenes providing potyviPlasmids ral resistance, it is now recognized that the same mechanism can be targeted against parts of the viral genome Two binary plasmid constructs were prepared for Agrobacterium-mediated transformation of tobacco leaf discs. The plasmid pCPD44 contains the CP ORF and signal of the nopaline synthase terminator of pROK2 (Jef-CPD44 and CPD3, derived from transformation experiments using plasmids pCP3D44 and pCP3D3, respecferson et al., 1987) . A four-step cloning procedure was followed to introduce the PVX sequence into the binary tively, were collected for these studies. vector. First, a partial PVX cDNA clone (pPVXF) con-
In vitro transcription and inoculation of tobacco taining the 3 half of the PVX genome (Kavanagh et al., 1992) was linearized with ApaI restriction enzyme and Infectious transcripts of PVX plasmids or the TMV treated with nuclease Bal31. Second, a Bal31-SstI fragcDNA clone pTB2 (Donson et al., 1991) were prepared ment of approximately 700 bp (corresponding in size to using T7 polymerase and m7G(ppp)G cap analogue, as the region from the 5 end of the CP ORF to the 3 end described previously (Chapman et al., 1992b) . For some of the PVX genome) was isolated and ligated to EcoRVexperiments a crude sap inoculum containing PVX viriSstI-linearized pUBS19 (a derivative of pUC19) (Murphy ons was prepared from systemically infected N. tabacum and Kavanagh, 1988) to produce the plasmid pUBSD44 or N. clevelandii by homogenization of tissue in cold 50 in which the PVX cDNA extended 44 bp 5 of the coat mM borate buffer (pH 8.2). Extracts were filtered through protein coding region. The PVX cDNA was excised from miracloth or spun at low speed and the supernatant was pUBS19 by digestion with ClaI and SstI and ligated to used directly as a virion inoculum. Inocula of RNA were the ClaI-SstI-linearized pICI9H (Marsh et al., 1984) to prepared by grinding fresh tissue in RNA homogenization generate an intermediate plasmid. Finally the PVX cDNA buffer (Baulcombe et al., 1984) and by repeated extracwas isolated from the intermediate plasmid by digestion tions with phenol:chloroform. RNA was recovered by ethwith BamHI and SstI and inserted into pROK2 cut with anol precipitation and resuspended in water for use in the same enzymes.
plant inoculations. All plants were mechanically inocuThe binary vector pCPD3 contains nucleotides 5643-lated in the presence of carborundum. The titer of the 6133 of the PVX genome inserted into the pROK2 vector.
various inocula was assayed by inoculation of ChenoThe PVX infectious clone pTXS (Kavanagh et al., 1992) podium amaranticolor which is a local lesion host of PVX. was digested with TaqI enzyme and a fragment corresponding to nucleotides 5643-6133 was ligated to an Inoculation of protoplasts and Northern analysis AccI linearized pUC19 plasmid creating the plasmid Protoplasts were prepared as described previously pPVXTaq. An XbaI-StuI fragment derived from pPVXTaq (Chapman et al., 1992b) . Infectious transcripts were prewas ligated to an XbaI-StuI-linearized pCPD44 creating pared from 5 mg plasmid DNA in a 50-ml reaction and 10 pCPD3.
ml was used for each separate inoculation. ElectroporaThe PVX.GFP and the PVX.GFP.DCP plasmids are tion of plasmid transcripts was carried out as described clones of PVX cDNA with the GFP gene inserted adjapreviously (Chapman et al., 1992b) . Protoplasts were incent to a duplicated coat protein promoter and were cubated in the dark for 24 hr after inoculation and RNA described previously . The was extracted for Northern analysis in RNA homogeniza-PVX.GFP.DCP construct lacks most of the coat protein tion buffer, as described above. Of total RNA, 1.5 mg was gene up to nucleotide 6302 near the 3 end of the gene.
loaded per lane of a 0.9% w/v agarose formaldehyde gel. The PVX.GFP.FS plasmid contains a frameshift mutation Electrophoresis and Northern analysis was conducted near the 5 end of the coat protein ORF. This construct according to Sambrook et al. (1989) . The membrane was was prepared by restriction of PVX.GFP with NheI (nuprobed with a 32 P-labeled transcript of pTB2-CP in which cleotide position 5663 in the PVX genome). The Klenow the PVX CP ORF was substituted for the TMV CP ORF fragment of DNA pol I was used to fill in single strand (Bendahmane et al., 1995) . This probe hybridized to both ends of the restriction site and the plasmid was recircu-TMV and PVX RNAs. larized by ligation. The presence of the frameshift mutation was confirmed by sequence analysis. ELISA
The level of PVX in infected plants was determined Transformation and regeneration of tobacco by indirect ELISA using a monoclonal antibody (MAC58) specific for the coat protein of PVX (Torrance et al., 1986) . Binary plasmids were mobilized from Escherichia coli MC1022 into Agrobacterium tumefaciens strain LB4404
Four tobacco leaf discs were homogenized in 1 ml of ELISA extraction buffer (PBX, 0.05% Tween 20, 2% polyviby triparental mating using E. coli HB101 containing pRK2013 as the helper plasmid (Bevan, 1984) . Transconnylpyrrolidone) and 5-or 100-ml samples were used for this analysis. Plates were washed three times with PBST jugant A. tumefaciens were selected on kanamycin (50 mg/ml) and streptomycin (500 mg/ml) and used to trans-(PBX, 0.05% Tween 20) between additions of antibody solutions or plant sap extracts. Plant sap samples and form Nicotiana tabacum cv. Samsun NN leaf discs (Horsch et al., 1985) . Transformed shoots were regenerpurified PVX virion standards were added to microtiter plates precoated with anti-PVX rabbit polyclonal antibodated in MS medium. F1 and F2 progeny seed of lines AID VY 8732 / 6a46$$$$$2 08-15-97 08:55:04 viras AP: VY ies (10 mg/ml) diluted 1:1000 in carbonate buffer (15 mM Na 2 CO 3 , 35 mM NaHCO 3 ) and incubated at 4Њ overnight. Anti-PVX sera, diluted 1:1000 in PBST containing 0.2% BSA was added and the plates were incubated at 30Њ for 2 hr. Alkaline phosphatase-conjugated MAC58 diluted in PBST containing 0.2% BSA was added, incubated for 2 hr at 33Њ, and the microtiter plate was rinsed four times in PBST buffer. Substrate (p-nitrophenol phosphate in diethanolamine buffer, pH 9.8) was added to the microtiter plate, incubated at room temperature, and the absorbance was read at 405 nm. All solutions were as specified by the manufacturers protocol for the ELISA diagnostic kit (Bioreba A.G.) The lower detection limit by ELISA in this analysis was approximately 0.4 ng PVX/mg fresh tissue weight.
Immunosorbent electron microscopy
Samples of infected leaves were ground in 1:10 w/v of phosphate buffer, pH 7.0. PVX antisera was diluted 1:1000 in phosphate buffer, pH 7.0, and 20-ml drops were used to float carbon-coated gold grids (3.05 mm mesh). Grids were incubated 1 hr at 25-35Њ and after washing with phosphate buffer were floated on drops of extracted samples, left overnight at 4Њ, and subsequently washed three times with phosphate buffer and once with water. For electron microscopy the grids were stained with 2% uranyl acetate.
RESULTS

CP transgenes confer broad spectrum resistance against PVX
The tobacco cultivar Samsun NN was transformed with either of two Ti plasmid constructs containing cDNA of PVX isolate UK3 (PVX UK3 ) fused to the 35S promoter of CaMV (Fig. 1A) . The cDNA in the CPD3 construct extends from 7 bases upstream of the PVX CP ORF to the 3 end of the nontranslated region in the viral genome. The CPD44 construct differs only in that there are 44 bases To characterize the mechanism of PVX resistance in vascular transport of the virus . resistance mechanism operates at three levels. First, c ELISA of upper noninoculated leaves at 14 dpi revealed that the asymptomatic leaves had significantly less virus than in the symptomthere was suppression of the initial infection. This level atic leaves of nontransgenic plants (Spillane, unpublished data). In the of resistance was indicated in three replicate experimost extreme example, CPD3#4, there was no detectable PVX in the ments in which PVX.GFP was inoculated to nontransupper asymptomatic leaves. Fig. 1 and Tables 1  and 2 ). We attribute this higher resistance to the higher transgene copy number and more uniform segregation of the transgenes in the F2 generation. The F2 plants were also uniformly resistant against nonrecombinant (wild-type) PVX (CS and DCB, data not shown).
Suppression of PVX accumulation in protoplasts of line CPD3#4
PVX.GFP was inoculated to protoplasts to determine whether the PVX resistance in the F2 generation of line GFP infection foci on leaves of nontransgenic (NT) or CPD3#4 leaves inoculated with PVX.GFP (7 dpi), PVX.GFP.FS (14 dpi), or PVX.GFP.DCP (14 dpi). The leaves were photographed under UV light. The right hand panels show immunosorbent electron microscopy of virus particles isolated from the infection foci. The scale bar in these electron micrographs is 0.5 mm.
CPD3#4 was due to suppression of virus accumulation artefact due to the condition of the protoplasts of line CPD3#4. within initially infected cells. Northern analysis of protoplast RNA extracted at 24 hr postinoculation revealed
The protoplasts of line CPD3#4 were also inoculated with two mutant viruses, PVX.GFP.FS and PVX.GFP.DCP that the positive strand RNA of PVX.GFP accumulated in nontransgenic protoplasts (Fig. 3B, lanes 7 and 8) . (Fig. 3A) . The PVX.GFP.FS mutant has a frameshift mutation at the beginning of the coat protein ORF while most However, in the protoplasts of line CPD3#4, PVX.GFP RNA failed to accumulate to detectable levels (Fig. 3B , of the CP ORF is deleted in PVX.GFP.DCP . The mutant viral RNAs accumulated at sublanes 17 and 18). There was also suppression of PVX.GFP negative strand RNA accumulation (Fig. 3C , stantially lower levels in the CPD3#4 protoplasts than in protoplasts of a nontransgenic plant (Fig. 3B , lanes 3-6 lanes 3 and 4 compared with lanes 7 and 8), indicating that PVX replication in CPD3#4 protoplasts was inhibcompared with lanes 13-16). Thus, the CP mutations had no effect on the resistance observed in protoplasts ited. In contrast, TMV RNA accumulated to similar or slightly higher levels in the protoplasts of line CPD3#4 of line CPD3#4. Since neither of these mutant viruses would produce CP, this result shows that resistance does (Fig. 3B, lanes 9, 10, and 19) . From this control it can be ruled out that the low accumulation of PVX.GFP was an not require the CP of the inoculated virus. Similarly, be-AID VY 8732 / 6a46$$$$$3 08-15-97 08:55:04 viras AP: VY cause PVX.GFP.DCP was strongly suppressed in proto- (Angell and Baulcombe, 1997) . These data showed that transgenic lines expressing the 3 noncoding region of plasts of CPD3#4, it is concluded that the resistance does not require sequence similarity between the CP the PVX RNA as part of a defective PVX genome were not resistant against PVX. It is therefore more likely that ORF of the inoculated virus and the transgene.
the resistance in line CPD3#4 is protein-rather than PVX CP produced in line CPD3#4 complements a CP RNA-mediated. Consistent with this proposal are the obdefect in mutant PVX servations ( Fig. 1 and Table 2 ) that the resistance in line CPD3#4 is different from the RNA-mediated and Neither the PVX.GFP.DCP nor the PVX.GFP.FS muhomology-dependent virus resistance associated with tants can move out of the inoculated cells of nontransgene silencing: it is associated with high level extransgenic tobacco . However, pression of the CP transgene, whereas homology-depenafter inoculation to line CPD3#4, these mutant condent resistance is associated with low level transgene structs produced expanding GFP infection foci (Fig. 4) . expression; it is effective against a broader spectrum of The rate of expansion was similar to that of the foci PVX strains than homology-dependent resistance; it is produced when PVX.GFP was inoculated to line CPD3#4 overcome by high titer inocula, whereas homology-de- (Fig. 4 and data not shown) . Using immunosorbent elecpendent resistance is effective against high titer inocula. tron microscopy, PVX-like particles were identified in leaf
To explain the resistance and mutant-complementaextracts of line CPD3#4 inoculated with PVX.GFP.DCP tion phenotypes of line CPD3#4 we propose, as sugor the PVX.GFP.FS (Fig. 4) . We could rule out that the gested originally by Hemenway et al. (1988) , that the mobile, encapsidated virus was a product of recombinatransgenic CP interacts with the viral origin of assembly tion between the transgene RNA and the mutant virus (OAS) located in the 5 part of the PVX genome (Sit et because RT-PCR analysis revealed only the mutant PVX al., 1994) . If PVX moves between cells as virions, as RNAs in extracts of line CPD3#4 (data not shown). Theresuggested previously (Allison and Shalla, 1974 ; Chapfore, we conclude that the transgenic CP in line CPD3#4 man et al., 1992a; Oparka et al., 1996) , this interaction complemented the CP mutations in the inoculated PVX.
would rescue the cell-to-cell movement defect of the PVX However, there was no long distance movement of the CP mutants. Encapsidation would also sequester RNA, mutant isolates in any of the inoculated plants of line leaving a reduced pool of positive strand PVX RNA avail-CPD3#4.
able for replication. In addition, the interaction would block translation of the 5 ORF of the PVX genome that DISCUSSION encodes the PVX RNA polymerase (Huisman et al., 1988) . Both the reduced availability of positive strand RNA and In this description of line CPD3#4 we have confirmed that plants carrying PVX CP transgenes are resistant the block on RNA polymerase translation would result in low levels of PVX replication and accumulation in initially against PVX. In addition, we have shown that the PVX resistance was effective against a broad spectrum of infected cells and protoplasts. An attractive feature of this model is that a single inter-PVX strains ( Fig. 1 and Table 1 ), was expressed in the lines with the highest levels of CP transgene expression action, between the CP and the OAS, accounts for the reduced initial infection by PVX and the complementation (CS and TAK, unpublished data), and could be overcome by concentrated inocula (Fig. 1) . The primary level of of movement phenotypes of the CP transgenic line. Furthermore, the detection of PVX particles in extracts of resistance (i.e., suppression of PVX accumulation in the initially infected cells), was reflected in the fewer initial line CPD3#4 inoculated with the mutant PVX provides direct evidence that the proposed interaction of the CP infection sites on leaves and in the low level of PVX.GFP replication in protoplasts of the resistant plants. There and OAS was taking place in these plants (Fig. 4) . The resistance at the level of long distance movement was also suppression of PVX movement in the resistant plants affecting both cell-to-cell and long distance of PVX is outside the scope of this model. One likely explanation invokes suppression of long distance movespread.
In principle the resistance mechanism in line CPD3#4 ment as a secondary consequence of the reduced PVX replication in the PVX-resistant line. Alternatively there could be either protein-or RNA-mediated. However, if the resistance is RNA-based, it must involve the 133 could be separate resistance mechanisms affecting long distance movement and PVX replication. These alternanucleotide residues from the 3 noncoding region of the PVX genome. This is the only RNA that is common to tives are currently under investigation.
In practical terms the CP-mediated resistance mechaboth the transgene RNA and to the mutant PVX.GFP.DCP that was prevented from replicating in the protoplasts of nism described here has both advantages and disadvantages relative to other types of pathogen-derived resisline CPD3#4 (Fig. 3) . We consider that this small region of RNA is unlikely to confer the strong resistance that we tance against potexviruses. It has broader spectrum efficacy than the highly strain-specific homology-dependent have described here (Fig. 3) 
